Platelet-derived growth factor receptor/platelet-derived growth factor (PDGFR/PDGF) system is a prognostic and treatment response biomarker with multifarious therapeutic targets in cancers
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Platelet-derived growth factor receptor/platelet-derived growth factor (PDGFR/PDGF) system is a prognostic and treatment response biomarker with multifarious therapeutic targets in cancers
Authors
Keywords
PDGFR/PDGF system, Therapeutic targets, Prognostic marker, Treatment response biomarker, Small molecules, Immunotherapy, Gene therapy
Journal
TUMOR BIOLOGY
Volume 37, Issue 8, Pages 10053-10066
Publisher
Springer Nature
Online
2016-05-20
DOI
10.1007/s13277-016-5069-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- miR-126 regulates platelet-derived growth factor receptor-α expression and migration of primary human osteoblasts
- (2015) Yvonne Schmidt et al. BIOLOGICAL CHEMISTRY
- Blockade of the PDGFR family together with SRC leads to diminished proliferation of colorectal cancer cells
- (2015) Silke Kaulfuß et al. Oncotarget
- Development of a Fully Human Anti-PDGFRβ Antibody That Suppresses Growth of Human Tumor Xenografts and Enhances Antitumor Activity of an Anti-VEGFR2 Antibody
- (2015) Juqun Shen et al. NEOPLASIA
- Elevated PDGFRB gene copy number gain is prognostic for improved survival outcomes in resected malignant pleural mesothelioma
- (2014) Anne S. Tsao et al. Annals of Diagnostic Pathology
- Prognostic Impact of Major Receptor Tyrosine Kinase Expression in Gastric Cancer
- (2014) Yukinori Kurokawa et al. ANNALS OF SURGICAL ONCOLOGY
- MicroRNA-34A inhibits the growth, invasion and metastasis of gastric cancer by targeting PDGFR and MET expression
- (2014) Yang Peng et al. BIOSCIENCE REPORTS
- Biomimetic nanoparticles for siRNA delivery in the treatment of leukaemia
- (2014) Jianfeng Guo et al. BIOTECHNOLOGY ADVANCES
- A phase I dose-escalation study of MEDI-575, a PDGFRα monoclonal antibody, in adults with advanced solid tumors
- (2014) Carlos R. Becerra et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Phase I study of olaratumab in Japanese patients with advanced solid tumors
- (2014) Toshihiko Doi et al. CANCER SCIENCE
- miR-34a regulates mesangial cell proliferation via the PDGFR-β/Ras-MAPK signaling pathway
- (2014) Dapeng Chen et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- PDGF receptor signaling networks in normal and cancer cells
- (2014) Jean-Baptiste Demoulin et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Identification of Ponatinib as a potent inhibitor of growth, migration, and activation of neoplastic eosinophils carrying FIP1L1-PDGFRA
- (2014) Irina Sadovnik et al. EXPERIMENTAL HEMATOLOGY
- Randomized, Controlled, Double-Blind, Cross-Over Trial Assessing Treatment Preference for Pazopanib Versus Sunitinib in Patients With Metastatic Renal Cell Carcinoma: PISCES Study
- (2014) Bernard Escudier et al. JOURNAL OF CLINICAL ONCOLOGY
- Inhibition of Receptor Signaling and of Glioblastoma-derived Tumor Growth by a Novel PDGFRβ Aptamer
- (2014) Simona Camorani et al. MOLECULAR THERAPY
- Crenolanib is a selective type I pan-FLT3 inhibitor
- (2014) C. C. Smith et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The roles of platelet-derived growth factors and their receptors in brain radiation necrosis
- (2014) Tomo Miyata et al. Radiation Oncology
- Therapeutic potential of siRNA and DNAzymes in cancer
- (2014) Hanuma Kumar Karnati et al. TUMOR BIOLOGY
- Crenolanib, a PDGFR inhibitor, suppresses lung cancer cell proliferation and inhibits tumor growth in vivo
- (2014) Ping Wang et al. OncoTargets and Therapy
- Antiangiogenic cancer drug sunitinib exhibits unexpected proangiogenic effects on endothelial cells
- (2014) Kerri-Ann Norton et al. OncoTargets and Therapy
- A Recurrent PDGFRB Mutation Causes Familial Infantile Myofibromatosis
- (2013) Yee Him Cheung et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Crenolanib is a potent inhibitor of FLT3 with activity against resistance-conferring point mutants
- (2013) A. Galanis et al. BLOOD
- Large-scale Analysis of PDGFRA Mutations in Melanomas and Evaluation of Their Sensitivity to Tyrosine Kinase Inhibitors Imatinib and Crenolanib
- (2013) J. Dai et al. CLINICAL CANCER RESEARCH
- Pazopanib as Second-Line Treatment After Sunitinib or Bevacizumab in Patients With Advanced Renal Cell Carcinoma: A Sarah Cannon Oncology Research Consortium Phase II Trial
- (2013) John D. Hainsworth et al. Clinical Genitourinary Cancer
- Outcomes of patients with metastatic clear-cell renal cell carcinoma treated with pazopanib after disease progression with other targeted therapies
- (2013) M.R. Matrana et al. EUROPEAN JOURNAL OF CANCER
- Identification of novel FLT3 kinase inhibitors
- (2013) Daphnie Pauwels et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Expression and prognostic value of VEGFR-2, PDGFR-β, and c-Met in advanced hepatocellular carcinoma
- (2013) Jie Sheng Chu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Identification and elimination of target-related matrix interference in a neutralizing anti-drug antibody assay
- (2013) Martin Schwickart et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Resumption of imatinib to control metastatic or unresectable gastrointestinal stromal tumours after failure of imatinib and sunitinib (RIGHT): a randomised, placebo-controlled, phase 3 trial
- (2013) Yoon-Koo Kang et al. LANCET ONCOLOGY
- Non-small cell lung cancer cells survived ionizing radiation treatment display cancer stem cell and epithelial-mesenchymal transition phenotypes
- (2013) Roberto Gomez-Casal et al. Molecular Cancer
- Multifarious functions of PDGFs and PDGFRs in tumor growth and metastasis
- (2013) Yihai Cao TRENDS IN MOLECULAR MEDICINE
- Platelet-derived growth factors and their receptors: Structural and functional perspectives
- (2012) Po-Han Chen et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Abstract 1100: RNA aptamers as highly specific inhibitors of three human RTKs including Axl, EGFR and PDGFR
- (2012) Carla Lucia Esposito et al. CANCER RESEARCH
- Therapeutic RNA aptamers in clinical trials
- (2012) Padma Sundaram et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Recent advances and novel agents for gastrointestinal stromal tumor (GIST)
- (2012) Gurpreet Lamba et al. Journal of Hematology & Oncology
- Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
- (2012) Winette TA van der Graaf et al. LANCET
- Targeting Axl With an High-affinity Inhibitory Aptamer
- (2012) Laura Cerchia et al. MOLECULAR THERAPY
- A comparative study of PDGFR inhibition with imatinib on radiolabeled antibody targeting and clearance in two pathologically distinct models of colon adenocarcinoma
- (2012) Vineeth S. Rajkumar et al. TUMOR BIOLOGY
- Mutation in the platelet-derived growth factor receptor alpha inhibits adeno-associated virus type 5 transduction
- (2012) Ingo H. Pilz et al. VIROLOGY
- Serial measurements of serum PDGF-AA, PDGF-BB, FGF2, and VEGF in multiresistant ovarian cancer patients treated with bevacizumab
- (2012) Christine Madsen et al. Journal of Ovarian Research
- RNA interference: A futuristic tool and its therapeutic applications
- (2012) Anghesom Ambesajir et al. SAUDI JOURNAL OF BIOLOGICAL SCIENCES
- Trial Watch: Monoclonal antibodies in cancer therapy
- (2012) Lorenzo Galluzzi et al. OncoImmunology
- Acquired resistance to drugs targeting receptor tyrosine kinases
- (2011) Steven A. Rosenzweig BIOCHEMICAL PHARMACOLOGY
- Physical–chemical principles underlying RTK activation, and their implications for human disease
- (2011) Lijuan He et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Discovery of AZD2932, a new Quinazoline Ether Inhibitor with high affinity for VEGFR-2 and PDGFR tyrosine kinases
- (2011) Patrick A. Plé et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Multitargeted receptor tyrosine kinase inhibition: An antiangiogenic strategy in non-small cell lung cancer
- (2011) Mark A. Socinski CANCER TREATMENT REVIEWS
- PDGF-D Improves Drug Delivery and Efficacy via Vascular Normalization, But Promotes Lymphatic Metastasis by Activating CXCR4 in Breast Cancer
- (2011) J. Liu et al. CLINICAL CANCER RESEARCH
- Immunohistochemical Overexpression of Platelet-Derived Growth Factor Receptor–Beta (PDGFR-β) is Associated With PDGFRB Gene Copy Number Gain in Sarcomatoid Non–Small-Cell Lung Cancer
- (2011) Anne S. Tsao et al. Clinical Lung Cancer
- Adaptor protein Lnk binds to PDGF receptor and inhibits PDGF-dependent signaling
- (2011) Saskia Gueller et al. EXPERIMENTAL HEMATOLOGY
- Sorafenib for the management of advanced renal cell carcinoma
- (2011) Bernard Escudier Expert Review of Anticancer Therapy
- Platelet-derived growth factor and platelet-derived growth factor receptor-α expression in the normal human thymus and thymoma
- (2011) Anca Maria Cimpean et al. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
- MicroRNA-9 is an activation-induced regulator of PDGFR-beta expression in cardiomyocytes
- (2011) Jianhu Zhang et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Nilotinib versus imatinib for the treatment of patients with newly diagnosed chronic phase, Philadelphia chromosome-positive, chronic myeloid leukaemia: 24-month minimum follow-up of the phase 3 randomised ENESTnd trial
- (2011) Hagop M Kantarjian et al. LANCET ONCOLOGY
- Vascular endothelial growth factors and receptors: Anti-angiogenic therapy in the treatment of cancer
- (2011) Sònia Tugues et al. MOLECULAR ASPECTS OF MEDICINE
- Discovery and Development of Therapeutic Aptamers
- (2010) P.R. Bouchard et al. Annual Review of Pharmacology and Toxicology
- New insights into the mechanisms of hematopoietic cell transformation by activated receptor tyrosine kinases
- (2010) F. Toffalini et al. BLOOD
- Targeting pericytes with a PDGF-B aptamer in human ovarian carcinoma models
- (2010) Chunhua Lu et al. CANCER BIOLOGY & THERAPY
- Targeting the Receptor for Platelet-Derived Growth Factor as a Primary or Combination Therapy in a Preclinical Model of Prostate Cancer Skeletal Metastasis
- (2010) M. R. Russell et al. CLINICAL CANCER RESEARCH
- Pazopanib: Clinical development of a potent anti-angiogenic drug
- (2010) Fabio A.B. Schutz et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- 404 Phase I study of MEDI-575, a fully human monoclonal antibody targeting PDGFR-alpha in subjects with advanced solid tumors
- (2010) R. Lechleider et al. EJC SUPPLEMENTS
- Towards a targeted multi-drug delivery approach to improve therapeutic efficacy in breast cancer
- (2010) Bin Wang et al. Expert Opinion on Drug Delivery
- PDGFRA gene rearrangements are frequent genetic events in PDGFRA-amplified glioblastomas
- (2010) T. Ozawa et al. GENES & DEVELOPMENT
- A Phase II, open-label study evaluating pazopanib in patients with recurrent ovarian cancer
- (2010) Michael Friedlander et al. GYNECOLOGIC ONCOLOGY
- First-line treatment for chronic myeloid leukemia: dasatinib, nilotinib, or imatinib
- (2010) Guoqing Wei et al. Journal of Hematology & Oncology
- Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study
- (2010) Keith C Bible et al. LANCET ONCOLOGY
- RNA interference targeting the platelet-derived growth factor receptor β subunit ameliorates experimental hepatic fibrosis in rats
- (2010) Si-Wen Chen et al. LIVER INTERNATIONAL
- A Phase II Study of Pazopanib in Patients with Recurrent or Metastatic Invasive Breast Carcinoma: A Trial of the Princess Margaret Hospital Phase II Consortium
- (2010) S. K. Taylor et al. ONCOLOGIST
- Prognostic Significance of Stromal Platelet-Derived Growth Factor β-Receptor Expression in Human Breast Cancer
- (2009) Janna Paulsson et al. AMERICAN JOURNAL OF PATHOLOGY
- Response to a Novel Multitargeted Tyrosine Kinase Inhibitor Pazopanib in Metastatic Merkel Cell Carcinoma
- (2009) Matthew Davids et al. JOURNAL OF CLINICAL ONCOLOGY
- Imatinib in combination with hydroxyurea versus hydroxyurea alone as oral therapy in patients with progressive pretreated glioblastoma resistant to standard dose temozolomide
- (2009) Gregor Dresemann et al. JOURNAL OF NEURO-ONCOLOGY
- Immunotherapy in the landscape of new targeted treatments for non-small cell lung cancer
- (2009) Catherine Gérard et al. Molecular Oncology
- RNAi screen for rapid therapeutic target identification in leukemia patients
- (2009) J. W. Tyner et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Platelet-derived growth factor receptor as a prognostic marker and a therapeutic target for imatinib mesylate therapy in osteosarcoma
- (2008) Tadahiko Kubo et al. CANCER
- Combination of imatinib and vinorelbine enhances cell growth inhibition in breast cancer cells via PDGFR β signalling
- (2008) Marion T. Weigel et al. CANCER LETTERS
- Gene Expression Profile and Angiogenic Markers Correlate with Response to Neoadjuvant Bevacizumab Followed by Bevacizumab plus Chemotherapy in Breast Cancer
- (2008) S. X. Yang et al. CLINICAL CANCER RESEARCH
- Differential roles of PDGFR-α and PDGFR-β in angiogenesis and vessel stability
- (2008) Junhang Zhang et al. FASEB JOURNAL
- Role of platelet-derived growth factors in physiology and medicine
- (2008) J. Andrae et al. GENES & DEVELOPMENT
- Phase II Trial of Sorafenib in Advanced Thyroid Cancer
- (2008) Vandana Gupta-Abramson et al. JOURNAL OF CLINICAL ONCOLOGY
- MicroRNA Mirn140 modulates Pdgf signaling during palatogenesis
- (2008) Johann K Eberhart et al. NATURE GENETICS
- Role of PDGF in fibrotic diseases and systemic sclerosis
- (2008) M. Trojanowska RHEUMATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started